D-Dimer Is a Predictive Factor of Cancer Therapeutics-Related Cardiac Dysfunction in Patients Treated With Cardiotoxic Chemotherapy

BACKGROUND: D-dimer is a sensitive biomarker for cancer-associated thrombosis, but little is known about its significance on cancer therapeutics-related cardiac dysfunction (CTRCD). METHODS: Consecutive 169 patients planned for cardiotoxic chemotherapy were enrolled and followed up for 12 months. Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Oikawa, Masayoshi, Yaegashi, Daiki, Yokokawa, Tetsuro, Misaka, Tomofumi, Sato, Takamasa, Kaneshiro, Takashi, Kobayashi, Atsushi, Yoshihisa, Akiomi, Nakazato, Kazuhiko, Ishida, Takafumi, Takeishi, Yasuchika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813859/
https://www.ncbi.nlm.nih.gov/pubmed/35127869
http://dx.doi.org/10.3389/fcvm.2021.807754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813859/
https://www.ncbi.nlm.nih.gov/pubmed/35127869
http://dx.doi.org/10.3389/fcvm.2021.807754

Ejemplares similares